Welcome to our dedicated page for Amcor Plc SEC filings (Ticker: AMCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amcor plc filings document formal disclosures for a Jersey-incorporated packaging company with ordinary shares and several guaranteed senior notes listed on the New York Stock Exchange. Recent Form 8-K reports furnish quarterly and year-to-date financial results, guidance commentary, and cautionary forward-looking statement language tied to the company's operating performance.
The filing record also covers capital structure and debt activity, including guaranteed senior notes issued through Amcor UK Finance plc and guaranteed by Amcor and related entities. Governance disclosures include annual general meeting voting results, director elections and shareholder matters.
Amcor plc reported first‑quarter fiscal 2026 results. Net sales were $5,745 million and operating income was $461 million, reflecting the integration of Berry Global completed on April 30, 2025. Net income was $262 million, and diluted EPS was $0.113.
Costs tied to the combination were visible: amortization of acquired intangibles was $133 million and restructuring, transaction and integration expenses were $75 million. By segment, net sales were $3,257 million in Global Flexible Packaging Solutions and $2,488 million in Global Rigid Packaging Solutions.
Cash used in operating activities was $133 million. On the balance sheet, cash and cash equivalents were $825 million. Current portion of long‑term debt was $1,915 million and long‑term debt (less current) was $12,820 million. The company declared a dividend of $0.1275 per share. Shares outstanding were 2,308,359,941 as of November 4, 2025.
Amcor plc furnished an update on recent performance by submitting an Item 2.02 Form 8-K. The company made available its first quarter of fiscal year 2026 results through a press release attached as Exhibit 99.1.
The disclosure is expressly stated as furnished, not filed, which limits its use under Sections 18 of the Exchange Act and incorporation by reference rules. The filing also includes a customary forward-looking statements caution noting risks described in prior SEC reports.
Amcor plc's 2025 proxy statement reports operational and compensation outcomes and several governance proposals for shareholder votes. The company posted net sales of $15,009 million, GAAP net income of $511 million, adjusted EBIT of $1,723 million, adjusted EPS of 71.2 cps and adjusted free cash flow of $926 million. Safety metrics included a TRIR of 0.27 and 68% of sites injury-free for over 12 months. The filing discloses inclusion in Moody's ESG Investment Register, FTSE4Good and DJSI Australia and ratings such as CDP B, EcoVadis Gold and MSCI AA.
The proxy seeks shareholder approval to elect eleven directors, ratify PwC as auditor, approve Say-on-Pay and an annual frequency for advisory votes, and amend the Memorandum to permit a 1-for-5 reverse stock split. The filing states no related party transactions exceeded the Item 404 threshold in fiscal 2025 and describes executive compensation design, STI/LTI mechanics, clawback and share ownership requirements.
Jean-Marc Galvez, Chief Operating Officer, Global Rigids Packaging Solutions at Amcor plc, reported multiple Section 16 transactions on 09/15/2025. The filing shows a disposition of 568,460 ordinary shares. The report also records exercises of employee stock options: 1,306,722 options with an $8.28 exercise price exercisable 09/15/2028 and expiring 09/15/2035, resulting in 1,306,722 ordinary shares. Additionally, 79,697 restricted stock units were granted on 09/15/2025 and vest ratably over the first three anniversaries of the grant date. The form was signed by an attorney-in-fact on 09/17/2025.
Amcor plc (AMCR) insider reporting for Michael Casamento, Executive VP, Finance & CFO: The Form 4 shows transactions dated 09/15/2025 and was signed on 09/17/2025. The filing reports a disposition of 629,748 ordinary shares and several acquisitions the same day: exercise/acquisition of 761,585 shares via employee stock options (exercise price $8.28), and grants of restricted stock units totaling 128,451 RSUs (35,552 vesting on 09/15/2027 and 92,899 vesting ratably over three years). Of the disposed shares, 97,365 were held as CDIs. After the reported transactions, the filing lists 35,552 and 761,585 shares related to specific derivative holdings and 92,899 ordinary shares from RSUs as beneficially owned.
Peter Konieczny, listed as Chief Executive Officer and director of Amcor plc (AMCR), reported transactions dated 09/15/2025. The filing shows a disposition of 476,643 ordinary shares (non-derivative). On the same date the reporting person acquired derivative awards: 76,473 restricted stock units vesting 09/15/2027; an award of 3,910,738 employee stock options with an exercise price of $8.28, exercisable from 09/15/2028 and expiring 09/15/2035; and 238,517 restricted stock units that vest ratably over the first three anniversaries of the grant. Each restricted stock unit represents a contingent right to one ordinary share upon vesting. The form is signed by an attorney-in-fact on 09/17/2025.
Amcor plc (AMCR) reporting person Ian Wilson disclosed multiple transactions on 09/15/2025. He disposed of 337,384 ordinary shares and separately acquired equity awards the same day: 27,532 restricted stock units (RSUs) vesting beginning 09/15/2027, an additional 51,091 RSUs that vest ratably over three years, and 1,134,720 employee stock options with an $8.28 exercise price exercisable from 09/15/2028 through 09/15/2035. After the reported disposal and holdings, Wilson beneficially owns 168,592 shares directly and holds indirect interests of 114,286 shares through the Oscar Wilson Trust and 168,592 shares indirectly through Wilson Global Strategy Consultants as reported. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
Amcor plc (AMCR) Form 4 filed by Susana Suarez Gonzalez reports insider transactions on 09/15/2025. The filing shows a sale of 74,174 ordinary shares and grants/awards acquired the same date: 23,367 restricted stock units (RSUs) vesting 09/15/2027, 43,363 RSUs that vest ratably over three years, and 710,976 employee stock options with an exercise price of $8.28, exercisable beginning 09/15/2028 and expiring 09/15/2035. Each RSU converts to one ordinary share on vesting. The transactions were reported by an attorney-in-fact on 09/17/2025.
Deborah Rasin, General Counsel of Amcor plc (AMCR), reported multiple Section 16 transactions dated 09/15/2025. The Form 4 shows a disposition of 8,628 ordinary shares and the acquisition of several equity awards: 16,919 restricted stock units (RSUs) that represent contingent rights to one share each, 574,258 employee stock options with an exercise price of $8.28 (exercisable 09/15/2028 and expiring 09/15/2035), and an additional 35,024 RSUs that vest ratably on each of the first three anniversaries of the grant date. The Form indicates all reported derivative and non-derivative holdings are held directly. The filing is signed by an attorney-in-fact on 09/17/2025.
Amcor plc (AMCR) insider Julie Marie Sorrells reported multiple equity transactions dated 09/15/2025. The filing shows a disposition of 40,713 ordinary shares and an indirect holding of 7,674 shares through a 401(k) plan. On the same date she was granted equity awards: 9,467 restricted stock units vesting 09/15/2027, 69,703 employee stock options with an $8.28 exercise price exercisable from 09/15/2028 to 09/15/2035, and an additional 8,502 restricted stock units that vest ratably over three years. The form identifies her role as V.P. & Corporate Controller and is signed by an attorney-in-fact.